Syncona (LSE:SYNC) Notes Receivable : £0.00 Mil (As of Sep. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Syncona Notes Receivable?

Syncona's Notes Receivable for the quarter that ended in Sep. 2023 was £0.00 Mil.

Syncona Notes Receivable Historical Data

The historical data trend for Syncona's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syncona Notes Receivable Chart

Syncona Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Notes Receivable

Get a 7-Day Free Trial

Syncona Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Notes Receivable	Get a 7-Day Free Trial															-	-	-	-	-

Syncona Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Syncona Notes Receivable Related Terms

Thank you for viewing the detailed overview of Syncona's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Syncona (LSE:SYNC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Syncona Ltd (LSE:SYNC) » Definitions » Notes Receivable

Comparable Companies

Traded in Other Exchanges

SYNCl:UK

Address

8 Bloomsbury Street, 2nd Floor, London, GBR, WC1B 3SR

Website

https://www.synconaltd.com

Syncona Ltd is a closed-ended investment company in the United Kingdom. Its investment objective is to achieve superior long-term capital appreciation from its investments. The company invests in life science businesses (including private and quoted companies) and single or multi-asset projects (Life Science Investments).